ExchangeCoverageMedium impact
Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver
UnitedHealthcare·Oncology, Radiation Oncology, Radiology +1 more·Medical Policy
Effective date
Nov 1, 2026
We identified it
Sep 2, 2026
Summary
UnitedHealthcare has revised its medical policy on Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) for malignant liver cancers effective November 1, 2026. This is a revised policy affecting Exchange plans nationally. The billing team must review the specific coverage criteria, prior authorization requirements, and any billing code changes outlined in the full policy document to ensure compliant claims processing.
Action Required
By October 15, 2026: Billing team must obtain and review the complete UnitedHealthcare Exchange Medical Policy Update Bulletin (September 2026) from the source URL to identify: (1) specific CPT/HCPCS codes affected by this TARE/SIRT policy revision, (2) prior authorization requirements, and (3) any changes to coverage criteria. Update billing software rules, prior auth workflows, and provider documentation templates accordingly. Radiology, interventional radiology, and oncology providers must be notified of the policy changes. Beginning November 1, 2026, all TARE/SIRT claims for Exchange plan members must comply with updated requirements or face claim denials.